Evidence map›Paper›PMID 17565318›Full record

ArticleTransplantation2007

Spontaneous allograft tolerance in B7-deficient mice independent of preexisting endogenous CD4+CD25+ regulatory T-cells.

Todd J Grazia, Robert J Plenter, An N Doan, Brian P Kelly, Sarah M Weber, Jonathan S Kurche, Susan O Cushing, Ronald G Gill, Biagio A Pietra

Abstract read
In one paragraph

Article in Transplantation, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Prolongation of cardiac allograft survival by a novel population of autologous CD117+ bone marrow-derived progenitor cells.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Todd J GraziaDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of Colorado Health Sciences Center, and the Children's Hospital, Denver, CO 80262, USA. Todd.Grazia@uchsc.edu
Robert J Plenter
An N Doan
Brian P Kelly
Sarah M Weber
Jonathan S Kurche
Susan O Cushing
Ronald G Gill
Biagio A Pietra
Children's Hospital Colorado · US

Funding

REVERSAL OF DIABETES BY ISLET TRANSPLANTATIONR01DK033470 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI GILL, RONALD G · 1986 to 2006
$2.1M
CD4 T cell Dependent Acute Cardiac Allograft RejectionR01HL067976 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI PIETRA, BIAGIO A · 2001 to 2004
$1.2M
T cell Recognition and Injury of Cardiac AllograftsK08HL077503 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI GRAZIA, TODD J · 2005 to 2009
$674k
NHLBI NIH HHS K08 HL077503NHLBI NIH HHS R01 HL067976NHLBI NIH HHS R01 HL67976NIDDK NIH HHS R01 DK033470NIDDK NIH HHS R01 DK 33470
6 · The paper itself

Abstract

backgroundAcute cardiac allograft rejection requires host, but not donor, expression of B7-1/B7-2 costimulatory molecules. However, acute cardiac rejection requires direct antigen presentation by donor-derived antigen presenting cells to CD4 T-cells and does not require indirect antigen presentation to CD4 T-cells. Given this discrepancy in the literature and that the consequence of allograft exposure in B7-deficient mice is unknown; the goal of the study was to examine the antidonor status of allografted B7-1/B7-2-deficient hosts.

methodsC57Bl/6 B7-1/B7-2-/- mice were grafted with heterotopic BALB/c hearts. Recipients bearing long-term surviving allografts were used to examine the status of antidonor reactivity in vitro and in vivo. Tolerance was examined in vivo through adoptive transfer of splenocytes from graft-bearing animals to secondary immune-deficient Rag-1-/- hosts bearing donor-type or third-party cardiac allografts and by regulatory T-cell depletion with anti-CD25 antibody.

resultsWhen transferred to B7-replete Rag-1-/- recipients, cells from naïve B7-1/B7-2-/- mice readily initiated cardiac allograft rejection. However, splenocytes transferred from long-term allograft acceptor B7-1/B7-2-/- hosts failed to reject donor-type hearts but acutely rejected third-party allografts. In addition, such cells did not reject (donorxthird-party) F1 allografts. Finally, in vivo depletion of regulatory T-cells did not prevent long-term acceptance.

conclusionsResults demonstrate that B7-deficient T-cells are capable of acute cardiac allograft rejection in a B7-replete environment. Importantly, results also show that B7-deficient hosts do not simply ignore cardiac allografts, but rather spontaneously develop transferable, donor-specific tolerance and linked suppression in vivo. Interestingly, this tolerant state does not require endogenous CD4+CD25+ regulatory T-cells.

Indexed as

Immune ToleranceAnimalsB7-1 AntigenB7-2 AntigenForkhead Transcription FactorsGraft RejectionGraft SurvivalHeart TransplantationHomeodomain ProteinsInterleukin-2 Receptor alpha SubunitMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutMyocardiumSpleenB7-1 AntigenB7-2 AntigenForkhead Transcription FactorsFoxp3 protein, mouseHomeodomain ProteinsInterleukin-2 Receptor alpha SubunitRAG-1 protein

Identifiers

PMID17565318
PMCPMC4427242
OpenAlexW1978930067

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.